SE434457B - Forfarande for framstellning av en stabil, vattenhaltig oxitetracyklinlosning for parenteral, paroral och lokal anvendning - Google Patents

Forfarande for framstellning av en stabil, vattenhaltig oxitetracyklinlosning for parenteral, paroral och lokal anvendning

Info

Publication number
SE434457B
SE434457B SE7500401A SE7500401A SE434457B SE 434457 B SE434457 B SE 434457B SE 7500401 A SE7500401 A SE 7500401A SE 7500401 A SE7500401 A SE 7500401A SE 434457 B SE434457 B SE 434457B
Authority
SE
Sweden
Prior art keywords
paroral
oxitetracycline
parenteral
aqueous
preparing
Prior art date
Application number
SE7500401A
Other languages
English (en)
Swedish (sv)
Inventor
H P Ghilardi
K Atasoy
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE434457B publication Critical patent/SE434457B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7500401A 1974-02-19 1975-01-15 Forfarande for framstellning av en stabil, vattenhaltig oxitetracyklinlosning for parenteral, paroral och lokal anvendning SE434457B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH227674 1974-02-19

Publications (1)

Publication Number Publication Date
SE434457B true SE434457B (sv) 1984-07-30

Family

ID=4229973

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500401A SE434457B (sv) 1974-02-19 1975-01-15 Forfarande for framstellning av en stabil, vattenhaltig oxitetracyklinlosning for parenteral, paroral och lokal anvendning

Country Status (17)

Country Link
US (1) US4020162A (xx)
JP (1) JPS50129724A (xx)
AT (1) AT336793B (xx)
BE (1) BE825656A (xx)
CA (1) CA1052270A (xx)
DE (1) DE2506579A1 (xx)
DK (1) DK138974B (xx)
ES (1) ES434805A1 (xx)
FR (1) FR2261011B1 (xx)
GB (1) GB1494558A (xx)
IE (1) IE40663B1 (xx)
LU (1) LU71862A1 (xx)
MX (1) MX3044E (xx)
NL (1) NL7501248A (xx)
PH (1) PH11892A (xx)
SE (1) SE434457B (xx)
ZA (1) ZA751016B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
AU573321B2 (en) * 1984-03-14 1988-06-02 Jerome Corbiere Process for solubilizing active principles and pharmaceuticalcompositions thus obtained
JPS61130228A (ja) * 1984-11-29 1986-06-18 Sunstar Inc ミノサイクリンを安定に配合した組成物
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
JP5259392B2 (ja) * 2005-05-31 2013-08-07 ウォーソー・オーソペディック・インコーポレーテッド 疼痛を治療するための組成物および方法
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) * 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
CA2756924A1 (en) * 2009-03-26 2010-09-30 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Also Published As

Publication number Publication date
FR2261011B1 (xx) 1978-07-21
US4020162A (en) 1977-04-26
ES434805A1 (es) 1976-12-01
ZA751016B (en) 1976-01-28
DK138974C (xx) 1979-05-07
IE40663L (en) 1975-08-19
IE40663B1 (en) 1979-07-18
GB1494558A (en) 1977-12-07
DK4375A (xx) 1975-10-20
ATA119375A (de) 1976-09-15
MX3044E (es) 1980-03-04
AU7830775A (en) 1976-08-19
FR2261011A1 (xx) 1975-09-12
PH11892A (en) 1978-08-29
DE2506579A1 (de) 1975-08-21
AT336793B (de) 1977-05-25
DK138974B (da) 1978-11-27
NL7501248A (nl) 1975-08-21
CA1052270A (en) 1979-04-10
LU71862A1 (xx) 1975-12-09
JPS50129724A (xx) 1975-10-14
BE825656A (fr) 1975-08-18

Similar Documents

Publication Publication Date Title
SE434457B (sv) Forfarande for framstellning av en stabil, vattenhaltig oxitetracyklinlosning for parenteral, paroral och lokal anvendning
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE7508406L (sv) Forfarande for framstellning av polyfenylenoxid.
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
IT1075305B (it) Procedimento per preparare derivati del ciclopentenone
DK263175A (da) Fremgangsmade til fremstilling af insulin, insulinanaloge og -derivater
SE424443B (sv) Tiofensackariner for anvendning som sotningsmedel och forfarande for framstellning derav
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE7507238L (sv) Sampolymerisat, och forfarande for deras framstellning och anvendning.
AR223797A1 (es) Procedimiento para preparar nuevos derivados de 8-halo,metil o amino-3-alquilo sustituido-dibenzofurano
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE423100B (sv) 8-oxikinolin-metall-dimetylditokarbamatkomplex och forfarande for framstellning derav
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
SE422057B (sv) Forfarande for framstellning av vissa omega-substituerade omega-nor-13,14-dehydro-prostaglandiner
NO150965C (no) Fremgangsmaate for fremstilling av en xantanopploesning
SE7504413L (sv) Forfarande for framstellning av en ny antibiotisk substans.
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE421616B (sv) Forfarande for framstellning av 1-metyl-piperazin och 1,4-dimentylpiperazin
SE423799B (sv) Forfarande och anordning for framstellning av en serigrafisk schablon
AU8397675A (en) Insulin, analogs and derivatives thereof